Skip to main content
Premium Trial:

Request an Annual Quote

McKesson to Offer Proventys' Personalized Medicine Service

This article has been updated to include comments from a McKesson official.
 
NEW YORK (GenomeWeb News) – McKesson today announced that it would offer a personalized medicine knowledge service developed by privately held Proventys.
 
Durham, NC-based Proventys translates predictive data from traditional and emerging diagnostic tests — including genomics, proteomics, and metabolomics — into clinical decision support products.  
 
The firms will develop decision-support solutions that will work with McKesson's clinical applications that incorporate clinical, environmental, and genomic information to help providers determine the best course of treatment for an individual patient, Andrew Mellin, vice president of advanced clinical technology, McKesson Provider Technologies, told GenomeWeb Daily News via e-mail.
"We see Proventys’ solutions as having applicability to a broad spectrum of users in healthcare," said Mellin. "Certainly, physicians will benefit from having this type of information to provide more informed, individualized decisions. We also see these tools being helpful for payors and other constituents in healthcare." 

Proventys’ knowledge base will be added to McKesson’s Horizon Knowledge Center clinical content offering, the Atlanta-based firm said in a statement. Mellin added that Proventys' risk-prediction capabilities may eventually be incorporated into a broader  suite of healthcare solutions from McKesson.

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.